Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery- A Prospective Randomized Controlled Trial

NCT03519165 is registered in ClinicalTrials.gov with Tata Medical Center as lead sponsor.

NCT NCT03519165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03519165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery- A Prospective Randomized Controlled Trial
Lead sponsor
Tata Medical Center
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2016
Completion date
September 30, 2019
Enrollment
145 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer